Inc Research Holdings Stock Performance
| INCR Stock | USD 1.33 0.02 1.48% |
The company owns a Beta (Systematic Risk) of 0.52, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, INC Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding INC Research is expected to be smaller as well. At this point, INC Research Holdings has a negative expected return of -0.62%. Please make sure to check out INC Research's total risk alpha, as well as the relationship between the skewness and day median price , to decide if INC Research Holdings performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days INC Research Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Last Split Factor 946:4209 | Last Split Date 2021-04-08 |
1 | Automotive Electronics Control Management Market Size Expected to Attain USD 48.0 Billion by 2031, Growing at a 5.7 percent CAGR Amid Rising EV Adoption Transpa... | 10/21/2024 |
2 | Marcus Receives Outperform Rating from Barrington Research | 10/31/2024 |
3 | Alameda Research Files Lawsuit Against Waves Founder Ivanov to Recover 90M | 11/11/2024 |
4 | Acquisition by Gibertini Michael of 10567 shares of INC Research subject to Rule 16b-3 | 11/14/2024 |
5 | Newton On Track For States First Marijuana Research Facility | 11/18/2024 |
6 | California voters narrowly reject statewide minimum wage hike for the first time | 11/20/2024 |
7 | Groundbreaking New FDA-Approved Drug for Acute Leukemia First Administered at Florida Cancer Specialists Research Institute Sarasota Drug Development Unit | 11/22/2024 |
8 | Samenvatting Taiwan Semiconductor Research Institute selecteert IQM Spark-kwuantumcomputer om onderzoek te bevorderen | 11/26/2024 |
9 | PitchBooks Executive Vice President of Research Market Intelligence Named 2024 Inspiring Leader | 11/27/2024 |
10 | Creative Bioarray Launches Advanced Cell Migration and Invasion Assay Services to Accelerate Biomedical Research | 11/29/2024 |
| Begin Period Cash Flow | 232.6 M | |
| Free Cash Flow | -56.2 M |
INC |
INC Research Relative Risk vs. Return Landscape
If you would invest 210.00 in INC Research Holdings on September 3, 2024 and sell it today you would lose (77.00) from holding INC Research Holdings or give up 36.67% of portfolio value over 90 days. INC Research Holdings is currently does not generate positive expected returns and assumes 4.5% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than INC, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
INC Research Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for INC Research's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as INC Research Holdings, and traders can use it to determine the average amount a INC Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.137
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INCR |
Estimated Market Risk
| 4.5 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.14 actual daily | 0 Most of other assets perform better |
Based on monthly moving average INC Research is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INC Research by adding INC Research to a well-diversified portfolio.
INC Research Fundamentals Growth
INC Stock prices reflect investors' perceptions of the future prospects and financial health of INC Research, and INC Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on INC Stock performance.
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0024 | ||||
| Profit Margin | (0.24) % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 96.51 M | ||||
| Shares Outstanding | 45.77 M | ||||
| Price To Earning | 37.77 X | ||||
| Price To Book | 0.48 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 355.55 M | ||||
| Gross Profit | 102.56 M | ||||
| EBITDA | (23.9 M) | ||||
| Net Income | (63.53 M) | ||||
| Cash And Equivalents | 305.06 M | ||||
| Cash Per Share | 2.92 X | ||||
| Total Debt | 195.68 M | ||||
| Debt To Equity | 0.32 % | ||||
| Current Ratio | 1.87 X | ||||
| Book Value Per Share | 9.64 X | ||||
| Cash Flow From Operations | (53.63 M) | ||||
| Earnings Per Share | (0.39) X | ||||
| Market Capitalization | 61.78 M | ||||
| Total Asset | 786.61 M | ||||
| Retained Earnings | (204 M) | ||||
| Working Capital | 192.94 M | ||||
| Current Asset | 422.05 M | ||||
| Current Liabilities | 474.59 M | ||||
About INC Research Performance
Assessing INC Research's fundamental ratios provides investors with valuable insights into INC Research's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the INC Research is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 154.90 | 123.35 | |
| Return On Tangible Assets | (0.11) | (0.12) | |
| Return On Capital Employed | (0.07) | (0.07) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | (0.14) | (0.14) |
Things to note about INC Research Holdings performance evaluation
Checking the ongoing alerts about INC Research for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for INC Research Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| INC Research generated a negative expected return over the last 90 days | |
| INC Research may become a speculative penny stock | |
| INC Research has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 355.55 M. Net Loss for the year was (63.53 M) with profit before overhead, payroll, taxes, and interest of 102.56 M. | |
| INC Research Holdings currently holds about 305.06 M in cash with (53.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| INC Research has a frail financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company shares are held by company insiders | |
| Latest headline from kalkinemedia.com: Creative Bioarray Launches Advanced Cell Migration and Invasion Assay Services to Accelerate Biomedical Research |
- Analyzing INC Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether INC Research's stock is overvalued or undervalued compared to its peers.
- Examining INC Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating INC Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of INC Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of INC Research's stock. These opinions can provide insight into INC Research's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for INC Stock Analysis
When running INC Research's price analysis, check to measure INC Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INC Research is operating at the current time. Most of INC Research's value examination focuses on studying past and present price action to predict the probability of INC Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INC Research's price. Additionally, you may evaluate how the addition of INC Research to your portfolios can decrease your overall portfolio volatility.